What Next: TBD | Tech, power, and the future
Technology
The diabetes medication Ozempic has exploded in popularity, particularly amongst those in Hollywood looking to lose a few extra pounds. But a silver bullet for weight loss leads to a number of questions: Is “buying weight loss” via injection somehow worse than diet and exercise? Are so many people buying and using this drug that people who need it for its intended purpose are missing out? What happened to body positivity?
Guest: Matthew Schneier, feature writer for New York Magazine.
Host: Lizzie O’Leary
If you enjoy this show, please consider signing up for Slate Plus. Slate Plus members get benefits like zero ads on any Slate podcast, bonus episodes of shows like Slow Burn and Dear Prudence—and you’ll be supporting the work we do here on What Next TBD. Sign up now at slate.com/whatnextplus to help support our work.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Cities Are Running Out of Money
Is “Covid Flight” a Thing?
What's a City Without the Office?
A Hidden Side of Police Abuse
Why Remote Learning Failed
Is This the End of Facial Recognition?
Your Delivery Habit Isn't Helping
Trump and Twitter Go to War
What Is Elon Musk Thinking?
Decoding the Flood of COVID Data
Should You Get an Antibody Test?
How the Crisis Could Embolden Big Tech
Can We Really Make a Safe Vaccine in 18 Months?
Can the U.S. Really Track the Coronavirus?
The Limits of Coronavirus Predictions
Risking Your Life for $8.71
Where Are All the Tests?
Big Tech Eyes the Pandemic
What If They Close All the Schools?
Did the Internet Doom a Pregnancy?
Create your
podcast in
minutes
It is Free
Slow Burn
Slate Debates
What Next | Daily News and Analysis
Decoder Ring
Amicus With Dahlia Lithwick | Law, justice, and the courts